Recently, in JAMA Oncology, researchers report an eight-fold increase in the adjusted percentage of decedents who received “all care” at the end of life.
The authors looked at survey data from nearly 2000 next-of-kin surrogates of Health and Retirement Study participants with cancer who died between 2000 and 2012, including data from in-depth “exit” interviews conducted with the surrogates after the participant’s death. The HRS is a nationally representative, biennial, longitudinal panel study of US residents older than 50 years.
Patients receiving “all care possible” at EOL increased during the period (7% to 58%, P = .004). The authors concluded that “cancer care continues to be both highly intensive and geographically variable, likely driven in large part by local practice patterns instead of patients’ preferences.”
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.